Arante, Mary Ann B.
HRN: 23-98-33 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/18/2023
CEFUROXIME 500MG (TAB)
11/18/2023
11/27/2023
PO
1 Tab
BID
SP NSVD W REPAIR
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes